The article highlights several disruptive technologies reshaping the joint replacement market, focusing on innovations that extend beyond traditional implant design to transform the entire care pathway. Key areas of disruption include robotics and automation, which increase surgical precision and consistency; advanced materials and manufacturing (such as 3D-printed lattices and biologically inspired surfaces) that enhance osseointegration and longevity; digital tools and data analytics that support preoperative planning and postoperative monitoring; and patient-specific solutions like custom implants and smart instrumentation. These technologies are helping to improve functional outcomes, reduce variability, and lower overall costs, while also enabling new business models such as value-based care and outpatient arthroplasty services. The piece concludes that stakeholders—manufacturers, health systems, and surgeons—must align on evidence generation, regulatory strategy, and clinical integration to realize the full potential of these disruptive advancements in joint replacement.